Norditropin FlexPro, injektionsvæske, opløsning i fyldt pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Sogroya 15 mg/1.5 mL solution for injection in pre-filled pen, Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen
NN8640-4467
Phase 3 small_molecule active
Quick answer
Norditropin FlexPro, injektionsvæske, opløsning i fyldt pen, Sogroya 10 mg/1.5 mL solution for injection in pre-filled pen, Sogroya 15 mg/1.5 mL solution for injection in pre-filled pen, Sogroya 5 mg/1.5 mL solution for injection in pre-filled pen for Children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature is a Phase 3 program (small_molecule) at Novo Nordisk A/S with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novo Nordisk A/S
- Indication
- Children with short stature either born small for gestational age or with Turner syndrome, Noonan syndrome, or idiopathic short stature
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active